Development and validation of nomograms to predict survival of primary cervical lymphoma: A surveillance, epidemiology, and end results (SEER) database analysis

被引:0
作者
Fan, Wenjuan [1 ,2 ]
Sun, Shiwei [3 ]
Wang, Jie [2 ]
Lv, You [2 ]
Chen, Ying [2 ]
机构
[1] Xian 1 Hosp, Dept Gynecol, Xian, Peoples R China
[2] Capital Med Univ, Beijing TianTan Hosp, Dept Obstet & Gynecol, Beijing 100070, Peoples R China
[3] Shanxi Med Univ, Dept Urol, Taiyuan Cent Hosp, Taiyuan, Peoples R China
关键词
cervix tumors; nomogram; non-Hodgkin lymphoma; primary cervical lymphoma; SEER database; survival; FEMALE GENITAL-TRACT; B-CELL LYMPHOMA; CHEMOTHERAPY PLUS RITUXIMAB; MALIGNANT-LYMPHOMA; UTERUS; SITES; CHOP;
D O I
10.1097/MD.0000000000038528
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Due to the rarity of primary cervical lymphoma (PCL), the long-term survival of patients with cervical lymphoma and factors influencing survival are unknown. This study aimed to compare the survivals of patients with PCL and those with other cervical tumors and construct a clinical prediction model to assess the prognosis of patients with PCL. Patients with PCL from the Surveillance, Epidemiology, and End Results database were allocated randomly in a 7:3 ratio to the training and validation sets. Cox proportional hazard and Fine-Gray models were used to verify independent factors influencing overall survival (OS) and disease-specific survival (DSS), and nomograms were constructed. Receiver operating characteristic curve analysis and decision curve analysis (DCA) were used to test the performance and clinical utility of the models, respectively. We included 206 patients with PCL. The areas under the curves (AUCs) and DCA showed that all models had clinical benefits; The models constructed in this study had a predictive performance for patients with PCL. It can guide clinicians to rationalize the treatment plan for patients.
引用
收藏
页数:8
相关论文
共 28 条
[1]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
[2]   Primary Non-Hodgkin Uterine Lymphoma of the Cervix: A Literature Review [J].
Capsa, Cristina ;
Calustian, Laura Aifer ;
Antoniu, Sabina Antonela ;
Bratucu, Eugen ;
Simion, Laurentiu ;
Prunoiu, Virgiliu-Mihail .
MEDICINA-LITHUANIA, 2022, 58 (01)
[3]   MALIGNANT LYMPHOMA OF CERVIX UTERI - HISTOLOGY AND ULTRASTRUCTURE [J].
CARR, I ;
HILL, AS ;
HANCOCK, B ;
NEAL, FE .
JOURNAL OF CLINICAL PATHOLOGY, 1976, 29 (08) :680-686
[4]   Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: An analysis of the Surveillance, Epidemiology and End Results database [J].
Castillo, Jorge J. ;
Winer, Eric S. ;
Olszewski, Adam J. .
AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (03) :310-314
[5]   CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].
Coiffier, B ;
Lepage, E ;
Brière, J ;
Herbrecht, R ;
Tilly, H ;
Bouabdallah, R ;
Morel, P ;
Van den Neste, E ;
Salles, G ;
Gaulard, P ;
Reyes, F ;
Gisselbrecht, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242
[6]  
DS V., 2012, Online J Health Allied Sci, V11, P1
[7]   Primary diffuse large B-cell lymphoma of the uterus A SEER database analysis [J].
Ensor, Allyne M. ;
Sanchez, Cesar Gentille ;
Ensor, Joe E. ;
Anand, Kartik .
MEDICINE, 2021, 100 (40) :E27359
[8]  
Glass AG, 1997, CANCER, V80, P2311
[9]   Primary diffuse large B cell lymphoma of Uterine Cervix: Treatment outcomes of a rare entity with literature review [J].
Goda, Jayant Sastri ;
Gaikwad, Utpal ;
Narayan, Anand ;
Kurkure, Durva ;
Yadav, Subhash ;
Khanna, Nehal ;
Jain, Hasmukh ;
Bagal, Bhausaheb ;
Epari, Sridhar ;
Singh, Priya ;
Sengar, Manju ;
Laskar, Siddharth .
CANCER REPORTS, 2020, 3 (05)
[10]   Lymphomas of the female genital tract - A study of 186 cases and review of the literature [J].
Kosari, F ;
Daneshbod, Y ;
Parwaresch, R ;
Krams, M ;
Wacker, HH .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (11) :1512-1520